Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001415889-25-006568

Options or other derivatives

  • Director acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
PAPADOPOULOS STELIOS Director 2025-03-03 Grant or award · Stock Option (right to buy) +90,000 90,000 D
Loading xslF345X05/form4-03042025_090327.xml…